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Clarification may be required with respect to
(1) the ethical grounds of providing additional protection to pregnant women and
(2) what constitutes additional protection to them.

Background
Today, blanket exclusion of pregnant
women from research participation is not
endorsed; however, a tendency still
remains to exclude pregnant women from
participating in research. This exclusion
results in insufficient data to guide clinical
practice for pregnant women, and hence
adds risks to pregnant women and fetuses
(Lyerly et al. 2007, 2008, 2009; Baylis 2010;
Goldkind et al. 2010).
The United States (US) Federal
Regulations classify pregnant women
together with fetuses and neonates as
populations requiring additional protection
(45 CFR 46 Subpart B).
The Council for International
Organizations and Medical Sciences
(CIOMS) Guidelines do not classify
pregnant women as a vulnerable
population; however, the CIOMS Guideline
17 provides certain conditions for their
research participation.

Arguments regarding pregnant women may pertain to women of
childbearing potential and lactating women, even if they are not currently
pregnant, depending on the reasons for additional protection.

Are there any problems with the
autonomy of pregnant women?
An autonomous person must have decisional
capacity and his/her voluntariness must be secured.
The Belmont Report stipulates that those with
“diminished autonomy are entitled to protection”.
This may apply to children (45 CFR 46 Subpart D) due
to their inadequate capacity and to prisoners (45 CFR
46 Subpart C) due to their plausible lack of
voluntariness. Physically or mentally disabled persons,
and economically or educationally disadvantaged
persons (46.107, 47.111) are also referred to as
vulnerable populations in the US Common Rule.
Coleman points out that it is not clear why certain
populations, such as pregnant women, are deemed
deficient in decisional capacity or voluntariness (2009).
Specifically regarding pregnant women’s decisional
capacity, the Committee on the Ethical and Legal
Issues Relating to the Inclusion of Women in Clinical
Studies (US) has clarified that pregnant women are
capable of making their own decisions (Mastroianni et
al. 1994). A similar view is expressed by the American
College of Obstetricians and Gynecologists (2007).

Beneficence regarding the fetus
Fetuses require special protection as they are not
autonomous agents. It may be the responsibility not only
of pregnant women, but also of healthcare professionals
and society to protect the fetus’ well-being. For the
ethical design and conduct of research involving pregnant
women, McCullough et al. argue that a fetus should be
recognized as a patient, and that maternal and fetal
interests must be balanced against each other (2005,
2008). However, the view of the fetus as a (fully distinct)
patient remains controversial.
In relation to the fetus, pregnant women face a wide
variety of challenges in making autonomous decisions
(Kukla et al. 2009). The CIOMS Guidelines express some
concern about the informed consent process of women
who live in societies where a woman is (1) expected not
to express herself, and (2) is considered less important
than her fetus (Guidelines 16 and 17). In addition to
physiological changes and anxiety due to pregnancy,
familial and societal values may undermine a pregnant
woman’s voluntariness in relation to her fetus. The
degree of such influences may differ across cultures and
communities.

